Emerging as a promising method in present healthcare, somachems represent a novel class of therapeutic agents. These intricate molecules are engineered to specifically bind with biological structures, allowing for remarkable targeting of pathological cells while minimizing damage to normal tissues. This specificity holds immense opportunity for man